Clinical effectiveness of quetiapine: findings of a post-Marketing surveillance study in patients with schizophrenia.
Standard
Clinical effectiveness of quetiapine: findings of a post-Marketing surveillance study in patients with schizophrenia. / Lambert, Martin; Reimitz, P E; Naber, Dieter.
in: INT J PSYCHIAT CLIN, Nr. 10, 2006, S. 204-212.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
Lambert, M, Reimitz, PE & Naber, D 2006, 'Clinical effectiveness of quetiapine: findings of a post-Marketing surveillance study in patients with schizophrenia.', INT J PSYCHIAT CLIN, Nr. 10, S. 204-212.
APA
Lambert, M., Reimitz, P. E., & Naber, D. (2006). Clinical effectiveness of quetiapine: findings of a post-Marketing surveillance study in patients with schizophrenia. INT J PSYCHIAT CLIN, (10), 204-212.
Vancouver
Lambert M, Reimitz PE, Naber D. Clinical effectiveness of quetiapine: findings of a post-Marketing surveillance study in patients with schizophrenia. INT J PSYCHIAT CLIN. 2006;(10):204-212.
Bibtex
@article{1126c435446c4cadbed47795b75a0a13,
title = "Clinical effectiveness of quetiapine: findings of a post-Marketing surveillance study in patients with schizophrenia.",
author = "Martin Lambert and Reimitz, {P E} and Dieter Naber",
year = "2006",
language = "English",
pages = "204--212",
journal = "INT J PSYCHIAT CLIN",
issn = "1365-1501",
publisher = "informa healthcare",
number = "10",
}
RIS
TY - JOUR
T1 - Clinical effectiveness of quetiapine: findings of a post-Marketing surveillance study in patients with schizophrenia.
AU - Lambert, Martin
AU - Reimitz, P E
AU - Naber, Dieter
PY - 2006
Y1 - 2006
M3 - SCORING: Journal article
SP - 204
EP - 212
JO - INT J PSYCHIAT CLIN
JF - INT J PSYCHIAT CLIN
SN - 1365-1501
IS - 10
ER -
